A5067342752- Pulmonary Hypertension Research and Treatments
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Cardiac Arrhythmias and Treatments
Chinese Academy of Medical Sciences & Peking Union Medical College
2022
Abstract Background Trimethylamine N-oxide (TMAO), the gut microbiota-dependent metabolite, is a potential biomarker in several cardiovascular diseases. However, no study has investigated its value pulmonary hypertension (PH). Therefore, this aimed to explore association between plasma TMAO levels and prognosis patients with PH. Methods Inpatients idiopathic/heritable arterial (IPAH/HPAH), PAH associated congenital heart disease (CHD-PAH), chronic thromboembolic (CTEPH) at Fuwai Hospital...
Abstract Background Arrhythmia is not uncommon among pulmonary hypertension (PH) population, and may be associated with disease severity. Hypothesis To investigate different spectrums prevalence of arrhythmias in clinical PH groups Chinese population. Methods Patients diagnosed between April 15, 2019, August 2, 2021, were enrolled prospectively. The types patients calculated. Logistic regression analyses conducted to determine independent predictors for arrhythmia. Results One thousand...